Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Tacconelli, Evelina
2009.
Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings.
Current Opinion in Infectious Diseases,
Vol. 22,
Issue. 4,
p.
352.
Li, Xian-Zhi
and
Nikaido, Hiroshi
2009.
Efflux-Mediated Drug Resistance in Bacteria.
Drugs,
Vol. 69,
Issue. 12,
p.
1555.
Ko, Wen-Chien
and
Hsueh, Po-Ren
2009.
Increasing extended-spectrum β-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: Data from the Smart Study 2002–2006.
Journal of Infection,
Vol. 59,
Issue. 2,
p.
95.
Kaye, Keith S.
Auwaerter, Paul
Bosso, John A.
Dean, Nathan C.
Doern, Gary V.
Kays, Michael B.
Pogue, Jason M.
Ritchie, David J.
and
Wispelwey, Brian
2010.
Strategies to Address Appropriate Fluoroquinolone Use in the Hospital.
Hospital Pharmacy,
Vol. 45,
Issue. 11,
p.
844.
Hsueh, Po-Ren
Badal, Robert E.
Hawser, Stephen P.
Hoban, Daryl J.
Bouchillon, Samuel K.
Ni, Yuxing
and
Paterson, David L.
2010.
Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia–Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
International Journal of Antimicrobial Agents,
Vol. 36,
Issue. 5,
p.
408.
Wener, Kenneth M.
Schechner, Vered
Gold, Howard S.
Wright, Sharon B.
and
Carmeli, Yehuda
2010.
Treatment with Fluoroquinolones or with β-Lactam-β-Lactamase Inhibitor Combinations Is a Risk Factor for Isolation of Extended-Spectrum-β-Lactamase-Producing
Klebsiella
Species in Hospitalized Patients
.
Antimicrobial Agents and Chemotherapy,
Vol. 54,
Issue. 5,
p.
2010.
Chen, Yen-Hsu
Hsueh, Po-Ren
Badal, Robert E.
Hawser, Stephen P.
Hoban, Daryl J.
Bouchillon, Samuel K.
Ni, Yuxing
and
Paterson, David L.
2011.
Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria.
Journal of Infection,
Vol. 62,
Issue. 4,
p.
280.
Bosso, J. A.
and
Drew, R. H.
2011.
Application of antimicrobial stewardship to optimise management of community acquired pneumonia.
International Journal of Clinical Practice,
Vol. 65,
Issue. 7,
p.
775.
Schechner, Vered
Kotlovsky, Tali
Tarabeia, Jalal
Kazma, Meital
Schwartz, David
Navon-Venezia, Shiri
and
Carmeli, Yehuda
2011.
Predictors of Rectal Carriage of Carbapenem-Resistant Enterobacteriaceae (CRE) among Patients with Known CRE Carriage at Their Next Hospital Encounter.
Infection Control & Hospital Epidemiology,
Vol. 32,
Issue. 5,
p.
497.
Vernaz, N.
Huttner, B.
Muscionico, D.
Salomon, J.-L.
Bonnabry, P.
Lopez-Lozano, J. M.
Beyaert, A.
Schrenzel, J.
and
Harbarth, S.
2011.
Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community.
Journal of Antimicrobial Chemotherapy,
Vol. 66,
Issue. 4,
p.
928.
Slavin, M. A.
Lingaratnam, S.
Mileshkin, L.
Booth, D. L.
Cain, M. J.
Ritchie, D. S.
Wei, A.
and
Thursky, K. A.
2011.
Use of antibacterial prophylaxis for patients with neutropenia.
Internal Medicine Journal,
Vol. 41,
Issue. 1b,
p.
102.
Dalhoff, Axel
2012.
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use.
Interdisciplinary Perspectives on Infectious Diseases,
Vol. 2012,
Issue. ,
p.
1.
Han, J. H.
Nachamkin, I.
Tolomeo, P.
Mao, X.
Bilker, W. B.
and
Lautenbach, E.
2012.
Risk Factors for Efflux Pump Overexpression in Fluoroquinolone-Resistant Escherichia coli.
Journal of Infectious Diseases,
Vol. 206,
Issue. 10,
p.
1597.
Han, Jennifer H.
Kasahara, Kei
Edelstein, Paul H.
Bilker, Warren B.
and
Lautenbach, Ebbing
2012.
Risk Factors for Infection or Colonization with CTX-M Extended-Spectrum-β-Lactamase-Positive Escherichia coli.
Antimicrobial Agents and Chemotherapy,
Vol. 56,
Issue. 11,
p.
5575.
Han, Jennifer H.
Nachamkin, Irving
Tolomeo, Pam
Mao, Xiangqun
Bilker, Warren B.
and
Lautenbach, Ebbing
2013.
Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones.
Diagnostic Microbiology and Infectious Disease,
Vol. 76,
Issue. 4,
p.
491.
Han, Jennifer H.
Bilker, Warren B.
Nachamkin, Irving
Tolomeo, Pam
Mao, Xiangqun
Fishman, Neil O.
and
Lautenbach, Ebbing
2013.
Impact of Antibiotic Use during Hospitalization on the Development of Gastrointestinal Colonization with Escherichia coli with Reduced Fluoroquinolone Susceptibility.
Infection Control & Hospital Epidemiology,
Vol. 34,
Issue. 10,
p.
1070.
Kim, Jungok
Kang, Cheol‐In
Joo, Eun‐Jeong
Ha, Young Eun
Cho, Sun Young
Gwak, Geum‐Youn
Chung, Doo Ryeon
Peck, Kyong Ran
and
Song, Jae‐Hoon
2014.
Risk factor of community‐onset spontaneous bacterial peritonitis caused by fluoroquinolone‐resistant Escherichia coli in patients with cirrhosis.
Liver International,
Vol. 34,
Issue. 5,
p.
695.
de Lastours, V.
Chau, F.
Roy, C.
Larroque, B.
and
Fantin, B.
2014.
Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.
Journal of Antimicrobial Chemotherapy,
Vol. 69,
Issue. 12,
p.
3393.
Han, J. H.
Maslow, J.
Han, X.
Xie, S. X.
Tolomeo, P.
Santana, E.
Carson, L.
and
Lautenbach, E.
2014.
Risk Factors for the Development of Gastrointestinal Colonization With Fluoroquinolone-Resistant Escherichia coli in Residents of Long-Term Care Facilities.
Journal of Infectious Diseases,
Vol. 209,
Issue. 3,
p.
420.
Han, Jennifer H.
Johnston, Brian
Nachamkin, Irving
Tolomeo, Pam
Bilker, Warren B.
Mao, Xiangqun
Clabots, Connie
Lautenbach, Ebbing
and
Johnson, James R.
2014.
Clinical and Molecular Epidemiology of Escherichia coli Sequence Type 131 among Hospitalized Patients Colonized Intestinally with Fluoroquinolone-Resistant E. coli.
Antimicrobial Agents and Chemotherapy,
Vol. 58,
Issue. 11,
p.
7003.